{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:26:36Z","timestamp":1790479596209,"version":"4.1.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Wahls Therapeutic Lifestyle Fund","award":["30578010"],"award-info":[{"award-number":["30578010"]}]},{"name":"Carter Chapman Shreve Fellowship","award":["30578009"],"award-info":[{"award-number":["30578009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The primary objective of this study is to evaluate the efficacy of two dietary interventions, time-restricted olive oil-based (TROO) ketogenic and modified Paleolithic elimination (MPE), compared to usual care control group receiving Dietary Guidelines for Americans (DGA) resources, on quality of life (QoL) among individuals with relapsing\u2013remitting multiple sclerosis (RRMS). The secondary objectives are to evaluate the long-term effects on functional disability, fatigue, mood, motor, ocular and cognitive function, and disease activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The proposed study will consist of 162 study participants attending 3 in-person site visits at months 0, 3, and 24, with online surveys every 3\u00a0months. This study will use a randomized, single-blind, controlled design to investigate the short-term (6\u00a0months) and long-term (24\u00a0months) efficacy of intervention diets on QoL and related outcomes stated above. On-site study visits will include motor, ocular and cognitive function, as well as magnetic resonance analyses. Blood and saliva biospecimens will be collected and frozen for future metabolome and microbiome analyses, respectively. Participants assigned to TROO keto and MPE diets will be given diet-specific educational materials and dietary supplements. Usual care control group will be given DGA resources and monthly educational resources. Dietary assessments will be collected by the Diet History Questionnaire III (DHQ III) at months 0, 3, 12 and 24. Registered Dietitian Nutritionists (RDNs) will deliver the dietary intervention to the TROO and MPE groups, using Social Cognitive Theory (SCT), Self-Determination Theory, and Motivational Interviewing (MI) techniques to facilitate effective behavior change.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>There is an unmet need for rigorous randomized controlled trials to assess the efficacy of dietary interventions on MS-related symptoms and disease activity. The findings from this study will provide necessary information regarding the role of specific dietary interventions in MS care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov, NCT05007483. Registered on August 16, 2021.\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT05007483\" ext-link-type=\"uri\">https:\/\/clinicaltrials.gov\/study\/NCT05007483<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-025-09157-2","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:29:43Z","timestamp":1761564583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of Diet on Quality of life in Multiple Sclerosis (EDQ-MS): a study protocol for a randomized controlled clinical trial"],"prefix":"10.1186","volume":"26","author":[{"given":"Farnoosh","family":"Shemirani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison R.","family":"Groux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Kilpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Ehlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren G.","family":"Darling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent A.","family":"Magnotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin F.","family":"Hoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Mangalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick Ten","family":"Eyck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo S.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Hook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler J.","family":"Titcomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda G.","family":"Snetselaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6059-7994","authenticated-orcid":false,"given":"Terry L.","family":"Wahls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"issue":"10130","key":"9157_CR1","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/s0140-6736(18)30481-1","volume":"391","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. Lancet. 2018;391(10130):1622\u201336. https:\/\/doi.org\/10.1016\/s0140-6736(18)30481-1.","journal-title":"Lancet"},{"key":"9157_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1295770","volume":"15","author":"X Wu","year":"2024","unstructured":"Wu X, Wang S, Xue T, Tan X, Li J, Chen Z, et al. Disease-modifying therapy in progressive multiple sclerosis: a systematic review and network meta-analysis of randomized controlled trials. Front Neurol. 2024;15:1295770. https:\/\/doi.org\/10.3389\/fneur.2024.1295770.","journal-title":"Front Neurol"},{"issue":"12","key":"9157_CR3","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1007\/s00415-019-09395-w","volume":"267","author":"H Li","year":"2020","unstructured":"Li H, Hu F, Zhang Y, Li K. Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing-remitting multiple sclerosis: a systematic review and network meta-analysis. J Neurol. 2020;267(12):3489\u201398. https:\/\/doi.org\/10.1007\/s00415-019-09395-w.","journal-title":"J Neurol"},{"issue":"6","key":"9157_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s40263-020-00734-4","volume":"34","author":"MH Chen","year":"2020","unstructured":"Chen MH, Goverover Y, Genova HM, DeLuca J. Cognitive efficacy of pharmacologic treatments in multiple sclerosis: a systematic review. CNS Drugs. 2020;34(6):599\u2013628. https:\/\/doi.org\/10.1007\/s40263-020-00734-4.","journal-title":"CNS Drugs"},{"key":"9157_CR5","doi-asserted-by":"crossref","unstructured":"Dunn M, Bhargava P, Kalb R. Your Patients with Multiple Sclerosis have Set Wellness as a High Priority\u2014And the National Multiple Sclerosis Society is Responding. US Neurology 2015;11(2):80\u20136.","DOI":"10.17925\/USN.2015.11.02.80"},{"issue":"4","key":"9157_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.7224\/1537-2073.2021-052","volume":"24","author":"SL Silveira","year":"2022","unstructured":"Silveira SL, Richardson EV, Motl RW. Desired resources for changing diet among persons with multiple sclerosis: qualitative inquiry informing future dietary interventions. Int J MS Care. 2022;24(4):175\u201383. https:\/\/doi.org\/10.7224\/1537-2073.2021-052.","journal-title":"Int J MS Care"},{"key":"9157_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00161","author":"RD Russell","year":"2018","unstructured":"Russell RD, Lucas RM, Brennan V, Sherriff JL, Begley A, et al. Reported changes in dietary behavior following a first clinical diagnosis of central nervous system demyelination. Front Neurol. 2018. https:\/\/doi.org\/10.3389\/fneur.2018.00161.","journal-title":"Front Neurol"},{"issue":"4","key":"9157_CR8","doi-asserted-by":"publisher","first-page":"e357","DOI":"10.1212\/wnl.0000000000201371","volume":"100","author":"LG Snetselaar","year":"2023","unstructured":"Snetselaar LG, Cheek JJ, Fox SS, Healy HS, Schweizer ML, Bao W, et al. Efficacy of diet on fatigue and quality of life in multiple sclerosis: a systematic review and network meta-analysis of randomized trials. Neurology. 2023;100(4):e357\u201366. https:\/\/doi.org\/10.1212\/wnl.0000000000201371.","journal-title":"Neurology"},{"key":"9157_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.101393","volume":"36","author":"E Evans","year":"2019","unstructured":"Evans E, Levasseur V, Cross AH, Piccio L. An overview of the current state of evidence for the role of specific diets in multiple sclerosis. Mult Scler Relat Disord. 2019;36:101393. https:\/\/doi.org\/10.1016\/j.msard.2019.101393.","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"9157_CR10","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/hex.13226","volume":"24","author":"RD Russell","year":"2021","unstructured":"Russell RD, Black LJ, Begley A. Navigating dietary advice for multiple sclerosis. Health Expect. 2021;24(3):853\u201362. https:\/\/doi.org\/10.1111\/hex.13226.","journal-title":"Health Expect"},{"issue":"5","key":"9157_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004192.pub4","volume":"5","author":"NE Parks","year":"2020","unstructured":"Parks NE, Jackson-Tarlton CS, Vacchi L, Merdad R, Johnston BC. Dietary interventions for multiple sclerosis-related outcomes. Cochrane Database Syst Rev. 2020;5(5):Cd004192. https:\/\/doi.org\/10.1002\/14651858.CD004192.pub4.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"9157_CR12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s13668-018-0236-z","volume":"7","author":"I Katz Sand","year":"2018","unstructured":"Katz Sand I. The role of diet in multiple sclerosis: mechanistic connections and current evidence. Curr Nutr Rep. 2018;7(3):150\u201360. https:\/\/doi.org\/10.1007\/s13668-018-0236-z.","journal-title":"Curr Nutr Rep"},{"issue":"1","key":"9157_CR13","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1212\/wnl.0000000000004768","volume":"90","author":"KC Fitzgerald","year":"2018","unstructured":"Fitzgerald KC, Tyry T, Salter A, Cofield SS, Cutter G, Fox R, et al. Diet quality is associated with disability and symptom severity in multiple sclerosis. Neurology. 2018;90(1):e1\u201311. https:\/\/doi.org\/10.1212\/wnl.0000000000004768.","journal-title":"Neurology"},{"key":"9157_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103910","volume":"63","author":"A Saul","year":"2022","unstructured":"Saul A, Taylor BV, Blizzard L, Simpson-Yap S, Oddy WH, Probst YC, et al. Associations between diet quality and depression, anxiety, and fatigue in multiple sclerosis. Mult Scler Relat Disord. 2022;63:103910. https:\/\/doi.org\/10.1016\/j.msard.2022.103910.","journal-title":"Mult Scler Relat Disord"},{"issue":"7","key":"9157_CR15","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s11136-023-03361-w","volume":"32","author":"H Kirkland","year":"2023","unstructured":"Kirkland H, Campbell J, Reece J, Nag N, Probst Y, Neate S, et al. Higher diet quality is associated with short and long-term benefits on SF-6D health state utilities: a 5-year cohort study in an international sample of people with multiple sclerosis. Qual Life Res. 2023;32(7):1883\u201396. https:\/\/doi.org\/10.1007\/s11136-023-03361-w.","journal-title":"Qual Life Res"},{"key":"9157_CR16","doi-asserted-by":"publisher","unstructured":"Jaftha M, Robertson F, Rensburg SJv, Kidd M, Toorn Rv, Kemp MC, et al. White matter lesion volumes on 3-T MRI in people with MS who had followed a diet- and lifestyle program for more than 10 years. medRxiv 2024:2024.04.04.24305252. https:\/\/doi.org\/10.1101\/2024.04.04.24305252.","DOI":"10.1101\/2024.04.04.24305252"},{"issue":"8","key":"9157_CR17","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1177\/13524585231167739","volume":"29","author":"AM Saul","year":"2023","unstructured":"Saul AM, Taylor BV, Blizzard L, Simpson-Yap S, Oddy WH, Shivappa N, et al. A pro-inflammatory diet in people with multiple sclerosis is associated with an increased rate of relapse and increased FLAIR lesion volume on MRI in early multiple sclerosis: a prospective cohort study. Mult Scler. 2023;29(8):1012\u201323. https:\/\/doi.org\/10.1177\/13524585231167739.","journal-title":"Mult Scler"},{"issue":"4","key":"9157_CR18","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000565","volume":"6","author":"JN Brenton","year":"2019","unstructured":"Brenton JN, Banwell B, Bergqvist AGC, Lehner-Gulotta D, Gampper L, Leytham E, et al. Pilot study of a ketogenic diet in relapsing-remitting MS. Neurol Neuroimmunol Neuroinflamm. 2019;6(4):e565. https:\/\/doi.org\/10.1212\/NXI.0000000000000565.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"9157_CR19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/jnnp-2022-329074","volume":"93","author":"JN Brenton","year":"2022","unstructured":"Brenton JN, Lehner-Gulotta D, Woolbright E, Banwell B, Bergqvist AGC, Chen S, et al. Phase II study of ketogenic diets in relapsing multiple sclerosis: safety, tolerability and potential clinical benefits. J Neurol Neurosurg Psychiatry. 2022;93(6):637\u201344. https:\/\/doi.org\/10.1136\/jnnp-2022-329074.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"9157_CR20","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.clnu.2023.06.029","volume":"42","author":"E Wetmore","year":"2023","unstructured":"Wetmore E, Lehner-Gulotta D, Florenzo B, Banwell B, Bergqvist AGC, Coleman R, et al. Ketogenic diet in relapsing multiple sclerosis: patient perceptions, post-trial diet adherence & outcomes. Clin Nutr. 2023;42(8):1427\u201335. https:\/\/doi.org\/10.1016\/j.clnu.2023.06.029.","journal-title":"Clin Nutr"},{"key":"9157_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/dnnd.S116949","volume":"7","author":"AK Irish","year":"2017","unstructured":"Irish AK, Erickson CM, Wahls TL, Snetselaar LG, Darling WG. Randomized control trial evaluation of a modified Paleolithic dietary intervention in the treatment of relapsing-remitting multiple sclerosis: a pilot study. Degener Neurol Neuromuscul Dis. 2017;7:1\u201318. https:\/\/doi.org\/10.2147\/dnnd.S116949.","journal-title":"Degener Neurol Neuromuscul Dis"},{"issue":"1","key":"9157_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/07315724.2020.1734988","volume":"40","author":"JE Lee","year":"2021","unstructured":"Lee JE, Titcomb TJ, Bisht B, Rubenstein LM, Louison R, Wahls TL. A modified MCT-based ketogenic diet increases plasma \u03b2-hydroxybutyrate but has less effect on fatigue and quality of life in people with multiple sclerosis compared to a modified Paleolithic diet: a waitlist-controlled, randomized pilot study. J Am Coll Nutr. 2021;40(1):13\u201325. https:\/\/doi.org\/10.1080\/07315724.2020.1734988.","journal-title":"J Am Coll Nutr"},{"issue":"3","key":"9157_CR23","doi-asserted-by":"publisher","first-page":"205521732110353","DOI":"10.1177\/20552173211035399","volume":"7","author":"TL Wahls","year":"2021","unstructured":"Wahls TL, Titcomb TJ, Bisht B, Eyck PT, Rubenstein LM, Carr LJ, et al. Impact of the Swank and Wahls elimination dietary interventions on fatigue and quality of life in relapsing-remitting multiple sclerosis: The WAVES randomized parallel-arm clinical trial. Mult Scler J Exp Transl Clin. 2021;7(3):20552173211035400. https:\/\/doi.org\/10.1177\/20552173211035399.","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"3","key":"9157_CR24","doi-asserted-by":"publisher","first-page":"205521732110353","DOI":"10.1177\/20552173211035399","volume":"7","author":"TL Wahls","year":"2021","unstructured":"Wahls TL, Titcomb TJ, Bisht B, Eyck PT, Rubenstein LM, Carr LJ, et al. Impact of the Swank and Wahls elimination dietary interventions on fatigue and quality of life in relapsing-remitting multiple sclerosis: The WAVES randomized parallel-arm clinical trial. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2021;7(3):20552173211035400. https:\/\/doi.org\/10.1177\/20552173211035399.","journal-title":"Multiple Sclerosis Journal - Experimental, Translational and Clinical"},{"key":"9157_CR25","doi-asserted-by":"publisher","first-page":"1087126","DOI":"10.3389\/fneur.2022.1087126","volume":"13","author":"BC Wingo","year":"2022","unstructured":"Wingo BC, Rinker JR 2nd, Green K, Peterson CM. Feasibility and acceptability of time-restricted eating in a group of adults with multiple sclerosis. Front Neurol. 2022;13:1087126. https:\/\/doi.org\/10.3389\/fneur.2022.1087126.","journal-title":"Front Neurol"},{"key":"9157_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102149","volume":"42","author":"SN Roman","year":"2020","unstructured":"Roman SN, Fitzgerald KC, Beier M, Mowry EM. Safety and feasibility of various fasting-mimicking diets among people with multiple sclerosis. Mult Scler Relat Disord. 2020;42:102149. https:\/\/doi.org\/10.1016\/j.msard.2020.102149.","journal-title":"Mult Scler Relat Disord"},{"key":"9157_CR27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.clnesp.2023.01.024","volume":"54","author":"N Arora","year":"2023","unstructured":"Arora N, Pulimamidi S, Yadav H, Jain S, Glover J, Dombrowski K, et al. Intermittent fasting with ketogenic diet: A combination approach for management of chronic diseases. Clinical Nutrition ESPEN. 2023;54:166\u201374. https:\/\/doi.org\/10.1016\/j.clnesp.2023.01.024.","journal-title":"Clinical Nutrition ESPEN"},{"issue":"2","key":"9157_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/s1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162\u201373. https:\/\/doi.org\/10.1016\/s1474-4422(17)30470-2.","journal-title":"Lancet Neurol"},{"issue":"2","key":"9157_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/1090198104263660","volume":"31","author":"A Bandura","year":"2004","unstructured":"Bandura A. Health promotion by social cognitive means. Health Educ Behav. 2004;31(2):143\u201364. https:\/\/doi.org\/10.1177\/1090198104263660.","journal-title":"Health Educ Behav"},{"key":"9157_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1479-5868-9-18","volume":"9","author":"H Patrick","year":"2012","unstructured":"Patrick H, Williams GC. Self-determination theory: its application to health behavior and complementarity with motivational interviewing. Int J Behav Nutr Phys Act. 2012;9:18. https:\/\/doi.org\/10.1186\/1479-5868-9-18.","journal-title":"Int J Behav Nutr Phys Act"},{"issue":"1","key":"9157_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/nhh.0000000000000001","volume":"32","author":"N Coyne","year":"2014","unstructured":"Coyne N, Correnti D. Effectiveness of motivational interviewing to improve chronic condition self-management: what does the research show us? Home Healthc Nurse. 2014;32(1):56\u201363. https:\/\/doi.org\/10.1097\/nhh.0000000000000001.","journal-title":"Home Healthc Nurse"},{"issue":"6","key":"9157_CR32","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.jada.2010.03.021","volume":"110","author":"JM Spahn","year":"2010","unstructured":"Spahn JM, Reeves RS, Keim KS, Laquatra I, Kellogg M, Jortberg B, et al. State of the evidence regarding behavior change theories and strategies in nutrition counseling to facilitate health and food behavior change. J Am Diet Assoc. 2010;110(6):879\u201391. https:\/\/doi.org\/10.1016\/j.jada.2010.03.021.","journal-title":"J Am Diet Assoc"},{"issue":"1","key":"9157_CR33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1037\/0003-066x.55.1.68","volume":"55","author":"RM Ryan","year":"2000","unstructured":"Ryan RM, Deci EL. Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. Am Psychol. 2000;55(1):68\u201378. https:\/\/doi.org\/10.1037\/0003-066x.55.1.68.","journal-title":"Am Psychol"},{"key":"9157_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, G\u00f8tzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586. https:\/\/doi.org\/10.1136\/bmj.e7586.","journal-title":"BMJ"},{"issue":"3","key":"9157_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/bf02260859","volume":"4","author":"BG Vickrey","year":"1995","unstructured":"Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW. A health-related quality of life measure for multiple sclerosis. Qual Life Res. 1995;4(3):187\u2013206. https:\/\/doi.org\/10.1007\/bf02260859.","journal-title":"Qual Life Res"},{"issue":"2","key":"9157_CR36","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1177\/1352458513507817","volume":"20","author":"L Kappos","year":"2014","unstructured":"Kappos L, Gold R, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, et al. Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: the DEFINE study. Mult Scler. 2014;20(2):243\u201352. https:\/\/doi.org\/10.1177\/1352458513507817.","journal-title":"Mult Scler"},{"issue":"4","key":"9157_CR37","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/ana.21163","volume":"62","author":"RA Rudick","year":"2007","unstructured":"Rudick RA, Miller D, Hass S, Hutchinson M, Calabresi PA, Confavreux C, et al. Health-related quality of life in multiple sclerosis: effects of natalizumab. Ann Neurol. 2007;62(4):335\u201346. https:\/\/doi.org\/10.1002\/ana.21163.","journal-title":"Ann Neurol"},{"key":"9157_CR38","doi-asserted-by":"publisher","unstructured":"Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46(10):1121\u20133. https:\/\/doi.org\/10.1001\/archneur.1989.00520460115022.","DOI":"10.1001\/archneur.1989.00520460115022"},{"key":"9157_CR39","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.msard.2019.07.028","volume":"35","author":"S Rooney","year":"2019","unstructured":"Rooney S, McFadyen DA, Wood DL, Moffat DF, Paul PL. Minimally important difference of the fatigue severity scale and modified fatigue impact scale in people with multiple sclerosis. Mult Scler Relat Disord. 2019;35:158\u201363. https:\/\/doi.org\/10.1016\/j.msard.2019.07.028.","journal-title":"Mult Scler Relat Disord"},{"key":"9157_CR40","unstructured":"Guidelines MSCP. Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis. Washington DC: Paralyzed Veterans of America 1998."},{"issue":"6","key":"9157_CR41","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370. https:\/\/doi.org\/10.1111\/j.1600-0447.1983.tb09716.x.","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"9157_CR42","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.1097\/hcr.0000000000000379","volume":"39","author":"KR Lemay","year":"2019","unstructured":"Lemay KR, Tulloch HE, Pipe AL, Reed JL. Establishing the minimal clinically important difference for the Hospital Anxiety and Depression Scale in patients with cardiovascular disease. J Cardiopulm Rehabil Prev. 2019;39(6):E6-e11. https:\/\/doi.org\/10.1097\/hcr.0000000000000379.","journal-title":"J Cardiopulm Rehabil Prev"},{"issue":"2","key":"9157_CR43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.7224\/1537-2073.2013-013","volume":"16","author":"TM Watson","year":"2014","unstructured":"Watson TM, Ford E, Worthington E, Lincoln NB. Validation of mood measures for people with multiple sclerosis. Int J MS Care. 2014;16(2):105\u20139. https:\/\/doi.org\/10.7224\/1537-2073.2013-013.","journal-title":"Int J MS Care"},{"issue":"6","key":"9157_CR44","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1191\/0269215501cr427oa","volume":"15","author":"CR Nicholl","year":"2001","unstructured":"Nicholl CR, Lincoln NB, Francis VM, Stephan TF. Assessment of emotional problems in people with multiple sclerosis. Clin Rehabil. 2001;15(6):657\u201368. https:\/\/doi.org\/10.1191\/0269215501cr427oa.","journal-title":"Clin Rehabil"},{"issue":"12","key":"9157_CR45","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1177\/1352458509347150","volume":"15","author":"K Honarmand","year":"2009","unstructured":"Honarmand K, Feinstein A. Validation of the hospital anxiety and depression scale for use with multiple sclerosis patients. Mult Scler. 2009;15(12):1518\u201324. https:\/\/doi.org\/10.1177\/1352458509347150.","journal-title":"Mult Scler"},{"issue":"2","key":"9157_CR46","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1212\/wnl.45.2.251","volume":"45","author":"MJ Hohol","year":"1995","unstructured":"Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: a simple approach to evaluate disease progression. Neurology. 1995;45(2):251\u20135. https:\/\/doi.org\/10.1212\/wnl.45.2.251.","journal-title":"Neurology"},{"issue":"1","key":"9157_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1191\/1352458505ms1136oa","volume":"11","author":"AC Lo","year":"2005","unstructured":"Lo AC, Hadjimichael O, Vollmer TL. Treatment patterns of multiple sclerosis patients: a comparison of veterans and non-veterans using the NARCOMS registry. Mult Scler. 2005;11(1):33\u201340. https:\/\/doi.org\/10.1191\/1352458505ms1136oa.","journal-title":"Mult Scler"},{"issue":"11","key":"9157_CR48","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1212\/01.wnl.0000218309.01322.5c","volume":"66","author":"G Kobelt","year":"2006","unstructured":"Kobelt G, Berg J, Atherly D, Hadjimichael O. Costs and quality of life in multiple sclerosis: a cross-sectional study in the United States. Neurology. 2006;66(11):1696\u2013702. https:\/\/doi.org\/10.1212\/01.wnl.0000218309.01322.5c.","journal-title":"Neurology"},{"issue":"8","key":"9157_CR49","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1212\/01.wnl.0000208505.81912.82","volume":"66","author":"RA Marrie","year":"2006","unstructured":"Marrie RA, Cutter G, Tyry T, Vollmer T, Campagnolo D. Does multiple sclerosis-associated disability differ between races? Neurology. 2006;66(8):1235\u201340. https:\/\/doi.org\/10.1212\/01.wnl.0000208505.81912.82.","journal-title":"Neurology"},{"key":"9157_CR50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1471-2377-13-37","volume":"13","author":"YC Learmonth","year":"2013","unstructured":"Learmonth YC, Motl RW, Sandroff BM, Pula JH, Cadavid D. Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis. BMC Neurol. 2013;13:37. https:\/\/doi.org\/10.1186\/1471-2377-13-37.","journal-title":"BMC Neurol"},{"issue":"1","key":"9157_CR51","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s41687-023-00594-8","volume":"7","author":"N Greene","year":"2023","unstructured":"Greene N, Qu\u00e9r\u00e9 S, Bury DP, Mazerolle F, M\u2019Hari M, Loubert A, et al. Establishing clinically meaningful within-individual improvement thresholds for eight patient-reported outcome measures in people with relapsing-remitting multiple sclerosis. Journal of Patient-Reported Outcomes. 2023;7(1):61. https:\/\/doi.org\/10.1186\/s41687-023-00594-8.","journal-title":"Journal of Patient-Reported Outcomes"},{"issue":"5","key":"9157_CR52","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/1352458517690821","volume":"23","author":"RH Benedict","year":"2017","unstructured":"Benedict RH, DeLuca J, Phillips G, LaRocca N, Hudson LD, Rudick R, et al. Validity of the symbol digit modalities test as a cognition performance outcome measure for multiple sclerosis. Mult Scler. 2017;23(5):721\u201333. https:\/\/doi.org\/10.1177\/1352458517690821.","journal-title":"Mult Scler"},{"issue":"6","key":"9157_CR53","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1177\/1352458516645869","volume":"23","author":"SL Costa","year":"2017","unstructured":"Costa SL, Genova HM, DeLuca J, Chiaravalloti ND. Information processing speed in multiple sclerosis: past, present, and future. Mult Scler. 2017;23(6):772\u201389. https:\/\/doi.org\/10.1177\/1352458516645869.","journal-title":"Mult Scler"},{"issue":"7","key":"9157_CR54","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s40263-017-0444-x","volume":"31","author":"PJ Jongen","year":"2017","unstructured":"Jongen PJ. Health-related quality of life in patients with multiple sclerosis: impact of disease-modifying drugs. CNS Drugs. 2017;31(7):585\u2013602. https:\/\/doi.org\/10.1007\/s40263-017-0444-x.","journal-title":"CNS Drugs"},{"issue":"2","key":"9157_CR55","first-page":"77","volume":"25","author":"M Kellor","year":"1971","unstructured":"Kellor M, Frost J, Silberberg N, Iversen I, Cummings R. Hand strength and dexterity. Am J Occup Ther. 1971;25(2):77\u201383.","journal-title":"Am J Occup Ther"},{"issue":"2","key":"9157_CR56","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1191\/0269215504cr722oa","volume":"18","author":"TJ Bovend'Eerdt","year":"2004","unstructured":"Bovend\u2019Eerdt TJ, Dawes H, Johansen-Berg H, Wade DT. Evaluation of the modified Jebsen test of hand function and the University of Maryland arm questionnaire for stroke. Clin Rehabil. 2004;18(2):195\u2013202. https:\/\/doi.org\/10.1191\/0269215504cr722oa.","journal-title":"Clin Rehabil"},{"issue":"2","key":"9157_CR57","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1177\/1352458509354552","volume":"16","author":"AS Drake","year":"2010","unstructured":"Drake AS, Weinstock-Guttman B, Morrow SA, Hojnacki D, Munschauer FE, Benedict RH. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test. Mult Scler. 2010;16(2):228\u201337. https:\/\/doi.org\/10.1177\/1352458509354552.","journal-title":"Mult Scler"},{"issue":"2","key":"9157_CR58","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1191\/0269215502cr471oa","volume":"16","author":"P Feys","year":"2002","unstructured":"Feys P, Duportail M, Kos D, Van Asch P, Ketelaer P. Validity of the TEMPA for the measurement of upper limb function in multiple sclerosis. Clin Rehabil. 2002;16(2):166\u201373. https:\/\/doi.org\/10.1191\/0269215502cr471oa.","journal-title":"Clin Rehabil"},{"issue":"10","key":"9157_CR59","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1177\/1352458513475832","volume":"19","author":"I Lamers","year":"2013","unstructured":"Lamers I, Kerkhofs L, Raats J, Kos D, Van Wijmeersch B, Feys P. Perceived and actual arm performance in multiple sclerosis: relationship with clinical tests according to hand dominance. Mult Scler. 2013;19(10):1341\u20138. https:\/\/doi.org\/10.1177\/1352458513475832.","journal-title":"Mult Scler"},{"key":"9157_CR60","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2147\/PROM.S32241","volume":"3","author":"K Rasova","year":"2012","unstructured":"Rasova K, Martinkova P, Vyskotova J, Sedova M. Assessment set for evaluation of clinical outcomes in multiple sclerosis: psychometric properties. Patient Relat Outcome Meas. 2012;3:59\u201370. https:\/\/doi.org\/10.2147\/PROM.S32241.","journal-title":"Patient Relat Outcome Meas"},{"issue":"5","key":"9157_CR61","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1177\/1352458517690824","volume":"23","author":"P Feys","year":"2017","unstructured":"Feys P, Lamers I, Francis G, Benedict R, Phillips G, LaRocca N, et al. The nine-hole peg test as a manual dexterity performance measure for multiple sclerosis. Mult Scler. 2017;23(5):711\u201320. https:\/\/doi.org\/10.1177\/1352458517690824.","journal-title":"Mult Scler"},{"issue":"8","key":"9157_CR62","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1212\/wnl.58.8.1294","volume":"58","author":"SR Schwid","year":"2002","unstructured":"Schwid SR, Goodman AD, McDermott MP, Bever CF, Cook SD. Quantitative functional measures in MS: what is a reliable change? Neurology. 2002;58(8):1294\u20136. https:\/\/doi.org\/10.1212\/wnl.58.8.1294.","journal-title":"Neurology"},{"issue":"13","key":"9157_CR63","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1177\/1352458513483890","volume":"19","author":"YC Learmonth","year":"2013","unstructured":"Learmonth YC, Dlugonski DD, Pilutti LA, Sandroff BM, Motl RW. The reliability, precision and clinically meaningful change of walking assessments in multiple sclerosis. Mult Scler J. 2013;19(13):1784\u201391. https:\/\/doi.org\/10.1177\/1352458513483890.","journal-title":"Mult Scler J"},{"issue":"7","key":"9157_CR64","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1177\/1545968314521010","volume":"28","author":"I Baert","year":"2014","unstructured":"Baert I, Freeman J, Smedal T, Dalgas U, Romberg A, Kalron A, et al. Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehabilitation in multiple sclerosis: a European multicenter study. Neurorehabil Neural Repair. 2014;28(7):621\u201331. https:\/\/doi.org\/10.1177\/1545968314521010.","journal-title":"Neurorehabil Neural Repair"},{"issue":"5","key":"9157_CR65","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1177\/1352458517690823","volume":"23","author":"RW Motl","year":"2017","unstructured":"Motl RW, Cohen JA, Benedict R, Phillips G, LaRocca N, Hudson LD, et al. Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis. Mult Scler. 2017;23(5):704\u201310. https:\/\/doi.org\/10.1177\/1352458517690823.","journal-title":"Mult Scler"},{"issue":"21","key":"9157_CR66","doi-asserted-by":"publisher","first-page":"e1921","DOI":"10.1212\/WNL.0000000000008519","volume":"93","author":"MD Goldman","year":"2019","unstructured":"Goldman MD, LaRocca NG, Rudick RA, Hudson LD, Chin PS, Francis GS, et al. Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data. Neurology. 2019;93(21):e1921\u201331. https:\/\/doi.org\/10.1212\/WNL.0000000000008519.","journal-title":"Neurology"},{"issue":"Suppl 3","key":"9157_CR67","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1212\/WNL.0b013e3181dbb571","volume":"74","author":"CH Polman","year":"2010","unstructured":"Polman CH, Rudick RA. The multiple sclerosis functional composite: a clinically meaningful measure of disability. Neurology. 2010;74(Suppl 3):S8-15. https:\/\/doi.org\/10.1212\/WNL.0b013e3181dbb571.","journal-title":"Neurology"},{"issue":"1","key":"9157_CR68","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1191\/1352458504ms972oa","volume":"10","author":"EL Hoogervorst","year":"2004","unstructured":"Hoogervorst EL, Kalkers NF, Cutter GR, Uitdehaag BM, Polman CH. The patient\u2019s perception of a (reliable) change in the multiple sclerosis functional composite. Mult Scler. 2004;10(1):55\u201360. https:\/\/doi.org\/10.1191\/1352458504ms972oa.","journal-title":"Mult Scler"},{"issue":"5","key":"9157_CR69","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1037\/0033-2909.83.5.880","volume":"83","author":"C Porac","year":"1976","unstructured":"Porac C, Coren S. The dominant eye. Psychol Bull. 1976;83(5):880\u201397.","journal-title":"Psychol Bull"},{"issue":"6","key":"9157_CR70","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/ana.22005","volume":"67","author":"LS Talman","year":"2010","unstructured":"Talman LS, Bisker ER, Sackel DJ, Long DA Jr, Galetta KM, Ratchford JN, et al. Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol. 2010;67(6):749\u201360. https:\/\/doi.org\/10.1002\/ana.22005.","journal-title":"Ann Neurol"},{"issue":"3","key":"9157_CR71","first-page":"109","volume":"2","author":"SQ Napoli","year":"2005","unstructured":"Napoli SQ, Bakshi R. Magnetic resonance imaging in multiple sclerosis. Rev Neurol Dis. 2005;2(3):109\u201316.","journal-title":"Rev Neurol Dis"},{"key":"9157_CR72","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028969","author":"CC Hemond","year":"2018","unstructured":"Hemond CC, Bakshi R. Magnetic resonance imaging in multiple sclerosis. Cold Spring Harb Perspect Med. 2018. https:\/\/doi.org\/10.1101\/cshperspect.a028969.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"12","key":"9157_CR73","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1001\/archneurol.2011.914","volume":"68","author":"M Filippi","year":"2011","unstructured":"Filippi M, Rocca MA, De Stefano N, Enzinger C, Fisher E, Horsfield MA, et al. Magnetic resonance techniques in multiple sclerosis: the present and the future. Arch Neurol. 2011;68(12):1514\u201320. https:\/\/doi.org\/10.1001\/archneurol.2011.914.","journal-title":"Arch Neurol"},{"issue":"4","key":"9157_CR74","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/nbm.698","volume":"14","author":"SW Provencher","year":"2001","unstructured":"Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 2001;14(4):260\u20134. https:\/\/doi.org\/10.1002\/nbm.698.","journal-title":"NMR Biomed"},{"issue":"2","key":"9157_CR75","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform"},{"key":"9157_CR76","unstructured":"Mcculloch CE, Neuhaus JM. Generalized Linear Mixed Models. Wiley StatsRef: Statistics Reference Online."},{"key":"9157_CR77","doi-asserted-by":"crossref","unstructured":"Akaike H. A New Look at the Statistical Model Identification. In: Parzen E, Tanabe K, Kitagawa G, editors. Selected Papers of Hirotugu Akaike. New York, NY: Springer New York; 1998. p. 215\u201322.","DOI":"10.1007\/978-1-4612-1694-0_16"},{"issue":"5","key":"9157_CR78","doi-asserted-by":"publisher","first-page":"235","DOI":"10.7224\/1537-2073.2021-051","volume":"24","author":"C Dean","year":"2022","unstructured":"Dean C, Parks S, Titcomb TJ, Arthofer A, Meirick P, Grogan N, et al. Facilitators of and barriers to adherence to dietary interventions perceived by women with multiple sclerosis and their support persons. Int J MS Care. 2022;24(5):235\u201341. https:\/\/doi.org\/10.7224\/1537-2073.2021-051.","journal-title":"Int J MS Care"},{"issue":"1","key":"9157_CR79","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s12883-022-02913-w","volume":"22","author":"MD Guerrero Aznar","year":"2022","unstructured":"Guerrero Aznar MD, Villanueva Guerrero MD, Cordero Ramos J, Eichau Madueno S, Morales Bravo M, Lopez Ruiz R, et al. Efficacy of diet on fatigue, quality of life and disability status in multiple sclerosis patients: rapid review and meta-analysis of randomized controlled trials. BMC Neurol. 2022;22(1):388. https:\/\/doi.org\/10.1186\/s12883-022-02913-w.","journal-title":"BMC Neurol"},{"issue":"4","key":"9157_CR80","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1212\/WNL.0000000000201565","volume":"100","author":"RI Spain","year":"2023","unstructured":"Spain RI, Piccio L, Langer-Gould AM. The role of diet in Multiple Sclerosis: food for thought. Neurology. 2023;100(4):167\u20138. https:\/\/doi.org\/10.1212\/WNL.0000000000201565.","journal-title":"Neurology"},{"key":"9157_CR81","unstructured":"Evidence review for non-pharmacological management of fatigue: Multiple sclerosis in adults: management: Evidence review C. London: National Institute for Health and Care Excellence (NICE); 2022 Jun. (NICE Guideline, No. 220.) Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK585277\/.\u00a0"},{"issue":"3","key":"9157_CR82","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/07315724.2016.1255160","volume":"36","author":"JE Lee","year":"2017","unstructured":"Lee JE, Bisht B, Hall MJ, Rubenstein LM, Louison R, Klein DT, et al. A multimodal, nonpharmacologic intervention improves mood and cognitive function in people with multiple sclerosis. J Am Coll Nutr. 2017;36(3):150\u201368. https:\/\/doi.org\/10.1080\/07315724.2016.1255160.","journal-title":"J Am Coll Nutr"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09157-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09157-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09157-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:08:33Z","timestamp":1761847713000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-09157-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9157"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09157-2","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"20 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the University of Iowa Institutional Review Board (IRB identifier 202104639). Informed consent is obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"This consent form constitutes a component of the informed consent procedure, obtainable upon request from the corresponding author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The author(s) declare the following potential conflicts of interest with respect to the research, authorship, and\/or publication of this article: Conflict of Interest Disclosures: Dr. Terry Wahls personally follows and promotes the Wahls\u2122 diet. She has equity interest in the following companies: Terry Wahls LLC; TZ Press LLC; The Wahls Institute, PLC; FBB Biomed Inc; Levels Health Inc., Foogal Inc. and the website\n                      \n                      . She also owns the copyright to the books Minding My Mitochondria (2nd Edition) and The Wahls Protocol, The Wahls Protocol Cooking for Life, and the trademarks The Wahls Protocol\u00ae and Wahls\u2122 diet, Wahls Paleo\u2122 diet, and Wahls Paleo Plus\u2122 diets and Wahls Behavior Change\u2122 model. She has completed grant funding from the National Multiple Sclerosis Society for the Dietary Approaches to Treating Multiple Sclerosis Related Fatigue Study. She has financial relationships with Vibrant America LLC, Standard Process Inc., MasterHealth Technologies Inc., Foogal Inc., Well Theory Technologies Inc., Vibrant America LLC, and the Institute for Functional Medicine Inc. She receives royalty payments from Penguin Random House. Dr Wahls has conflict of interest management plans in place with the University of Iowa and the Iowa City Veteran\u2019s Affairs Medical Center. All other authors report no personal or financial conflicts of interest in this work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"437"}}